Research and Markets: Osteoarthritis – Drug Development Lags Behind Rising Osteoarthritis Population
Childhood obesity: Strongest predictor of premature death
Read more on News-Medical-Net
In a study now being published in The New England Journal of Medicine, Associate Professor Paul Franks of Umeå University in Sweden, in collaboration with researchers in the US, shows how childhood obesity, together with other risk factors for cardiovascular disease, affects premature death.Use of non-steroidal anti-inflammatory drugs not associated with risk of squamous cell skin cancer
Read more on News-Medical-Net
Contrary to previous hypotheses, the use of non-steroidal anti-inflammatory drugs does not appear associated with risk of squamous cell skin cancer, according to a report posted online today that will appear in the April print issue of Archives of Dermatology, one of the JAMA/Archives journals.Certain pain medications do not appear to be associated with skin cancer risk
Read more on EurekAlert!
( JAMA and Archives Journals ) Contrary to previous hypotheses, the use of nonsteroidal anti-inflammatory drugs does not appear associated with risk of squamous cell skin cancer, according to a report posted online today that will appear in the April print issue of Archives of Dermatology, one of the JAMA/Archives journals.Global Rheumatoid Arthritis Therapeutics Market to Exceed $23.12 Billion by 2015, According to New Report by Global …
Read more on PRWeb via Yahoo! News
GIA announces the release of a comprehensive global report on Rheumatoid Arthritis Therapeutics markets.Research and Markets: Osteoarthritis – Drug Development Lags Behind Rising Osteoarthritis Population
Read more on Business Wire via Yahoo! Finance
DUBLIN—-Research and Markets has announced the addition of the “Stakeholder Insight: Osteoarthritis – Drug Development Lags behind Rising Osteoarthritis Population” report to their offering.
Leave a Comment